This site is intended for health professionals only!

Published on 18 May 2007

Share this story:

Collaboration on promising cancer drug

teaser

Two European drug firms are to collaborate on developing a promisingoncology compound. The UK’s Vernalis and France’s Servier will useVernalis’s proprietary drug discovery platform on an undisclosedtarget.

Vernalis chief executive Simon Sturge said thecollaboration with Servier followed on from a recent announcement thatanother of its partners, Novartis, had selected a second compound thatinhibits Hsp90, a target for a number of different cancer indications.

PharmaTimes 17/5/2007



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine